May 8, 2025 — The drugs, called NRTIs, have the potential to prevent a million cases of Alzheimer's every year, the researchers ... May 7, 2025 — Obstructive sleep apnea, a condition that ...

May 12, 2025 — In a recent study, researchers found adverse events were rare and manageable among clinic patients with very mild or mild Alzheimer's disease who received lecanemab ...

Randall Bateman, MD, Charles F and Joanne Knight Distinguished Professor of Neurology at WashU Medicine. A study of Roche's anti-amyloid drug gantenerumab has suggested that early treatment to ...

The saga of Cassava Sciences' development of Alzheimer's disease therapy simufilam has come to its dismal end. The company has reported top-line data from a second phase 3 trial of the drug ...

Dementia is caused when diseases, such as Alzheimer’s disease or a series of strokes, damage the brain. Dementia is progressive, which means the symptoms will gradually get worse. In most cases ...

Dementia together, Alzheimer’s Society’s magazine for people affected by dementia, is running its eighth poetry competition in 2025. Take part in our eighth Dementia together magazine poetry ...

Early use of lecanemab by Medicare beneficiaries with Alzheimer’s or mild cognitive impairment is marked by racial, ethnic, and socioeconomic disparities, a new study shows.